{"DataElement":{"publicId":"3187291","version":"1","preferredName":"Radiation Therapy Oncology Group Late Effects  Adverse Event Name","preferredDefinition":"Text name for a late morbidity event, using criteria from the Radiation Therapy Oncology Group (RTOG) to score/grade adverse events from radiation therapy.","longName":"RTOG_LT_EFF_AE_NM","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"3187278","version":"1","preferredName":"Radiation Therapy Oncology Group CTCAE Late Effects","preferredDefinition":"The Radiation Therapy Oncology Group (RTOG) is a multi-institutional cooperative organization, a national cancer study research group comprised of 250 of the major research institutions nationally and in Canada, funded by NCI, headquartered in Philadelphia with almost 30 years of experience in running clinical trials. More than 40 clinical trials that involve radiation therapy either alone or in conjunction with surgery and/or chemotherapeutic drugs are active at any one time within RTOG. The group is interested in quality of life issues and their effects on the cancer patient__A standard terminology developed to report adverse events occurring in cancer clinical trials.  Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration.  The CTCAE contain a grading scale for each adverse event term representing the severity of the event.","longName":"RTOG_CTCAE_LT_EFF","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"3187275","version":"1","preferredName":"Radiation Therapy Oncology Group Common Terminology Criteria for Adverse Events","preferredDefinition":"The Radiation Therapy Oncology Group (RTOG) is a multi-institutional cooperative organization, a national cancer study research group comprised of 250 of the major research institutions nationally and in Canada, funded by NCI, headquartered in Philadelphia with almost 30 years of experience in running clinical trials. More than 40 clinical trials that involve radiation therapy either alone or in conjunction with surgery and/or chemotherapeutic drugs are active at any one time within RTOG. The group is interested in quality of life issues and their effects on the cancer patient:A standard terminology developed to report adverse events occurring in cancer clinical trials.  Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration.  The CTCAE contain a grading scale for each adverse event term representing the severity of the event.","longName":"C19778:C49704","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Radiation Therapy Oncology Group","conceptCode":"C19778","definition":"A multi-institutional cooperative organization, a national cancer study research group comprised of 250 of the major research institutions nationally and in Canada, funded by NCI, headquartered in Philadelphia with almost 30 years of experience in running clinical trials. More than 40 clinical trials that involve radiation therapy either alone or in conjunction with surgery and/or chemotherapeutic drugs are active at any one time within RTOG. The group is interested in quality of life issues and their effects on the cancer patient","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Common Terminology Criteria for Adverse Events","conceptCode":"C49704","definition":"A standard terminology developed to report adverse events occurring in cancer clinical trials.  Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration.  The CTCAE contain a grading scale for each adverse event term representing the severity of the event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9AC65E5B-B5AA-5617-E040-BB89AD43498C","latestVersionIndicator":"Yes","beginDate":"2011-01-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-01-26","modifiedBy":"ONEDATA","dateModified":"2011-01-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3187276","version":"1","preferredName":"Late Effects","preferredDefinition":"Symptoms and conditions which are the result of treatment but arise months or years after the therapy.","longName":"C4808","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Late Adverse Effect","conceptCode":"C4808","definition":"Any symptom or condition which is a result of a medical intervention but arises months or years after it.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9AC65E5B-B5B8-5617-E040-BB89AD43498C","latestVersionIndicator":"Yes","beginDate":"2011-01-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-01-26","modifiedBy":"ONEDATA","dateModified":"2011-01-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9AC65E5B-B5C9-5617-E040-BB89AD43498C","latestVersionIndicator":"Yes","beginDate":"2011-01-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-01-26","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3187284","version":"1","preferredName":"Radiation Therapy Oncology Group Late Effects Adverse Event Name","preferredDefinition":"The Radiation Therapy Oncology Group (RTOG) is a multi-institutional cooperative organization, a national cancer study research group comprised of 250 of the major research institutions nationally and in Canada, funded by NCI, headquartered in Philadelphia with almost 30 years of experience in running clinical trials. More than 40 clinical trials that involve radiation therapy either alone or in conjunction with surgery and/or chemotherapeutic drugs are active at any one time within RTOG. The group is interested in quality of life issues and their effects on the cancer patient_Symptoms and conditions which are the result of treatment but arise months or years after the therapy._Any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, syndrome, or disease, temporally associated with the use of a medical product or procedure, regardless of whether or not it is considered related to the product or procedure (attribution of unrelated, unlikely, possible, probable, or definite). The concept refers to events that could be medical product related, dose related, route related, patient related, caused by an interaction with another therapy or procedure, or caused by opioid initiation or dose escalation. The term also is referred to as an adverse experience. The old term Side Effect is retired and should not be used.","longName":"RTOG_AE_LT_EFF_NM","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"24","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Joint","valueDescription":"Joint","ValueMeaning":{"publicId":"2873889","version":"1","preferredName":"Joint","longName":"2873889","preferredDefinition":"The point of connection between two bones or elements of a skeleton, especially if the articulation allows motion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Joint","conceptCode":"C13044","definition":"The connection point between two bones or skeletal elements. The joint may be fixed or movable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"696BC0F5-5DD7-4222-E040-BB89AD4378C7","latestVersionIndicator":"Yes","beginDate":"2009-05-08","endDate":null,"createdBy":"NYCHM","dateCreated":"2009-05-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9AC65E5B-B684-5617-E040-BB89AD43498C","beginDate":"2011-01-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-01-26","modifiedBy":"ONEDATA","dateModified":"2011-01-26","deletedIndicator":"No"},{"value":"Bone","valueDescription":"Bone","ValueMeaning":{"publicId":"2816296","version":"1","preferredName":"Bone","longName":"2816296","preferredDefinition":"Connective tissue that forms the skeletal components of the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bone","conceptCode":"C12366","definition":"The structural organ comprised of specialized connective tissue that forms the skeletal components of the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5E266FBD-28B8-AD47-E040-BB89A64327A4","latestVersionIndicator":"Yes","beginDate":"2008-12-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-12-16","modifiedBy":"FINCHAMB","dateModified":"2023-07-24","changeDescription":"Updated concept definition with current NCIt. 4.5.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9AC65E5B-B68F-5617-E040-BB89AD43498C","beginDate":"2011-01-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-01-26","modifiedBy":"ONEDATA","dateModified":"2011-01-26","deletedIndicator":"No"},{"value":"Bladder","valueDescription":"Bladder","ValueMeaning":{"publicId":"3123673","version":"1","preferredName":"Bladder","longName":"3123673","preferredDefinition":"A distensible musculomembranous organ serving as a receptacle for fluid, as the gallbladder.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder","conceptCode":"C12414","definition":"The distensible sac-like organ that functions as a reservoir of urine, collecting from the kidneys and eliminating via the urethra.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BC1C923-9BAD-5F51-E040-BB89AD4331F6","latestVersionIndicator":"Yes","beginDate":"2010-07-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-19","modifiedBy":"FINCHAMB","dateModified":"2023-07-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9AC65E5B-B699-5617-E040-BB89AD43498C","beginDate":"2011-01-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-01-26","modifiedBy":"ONEDATA","dateModified":"2011-01-26","deletedIndicator":"No"},{"value":"Small/Large Intestine","valueDescription":"Small and Large Intestine","ValueMeaning":{"publicId":"3153873","version":"1","preferredName":"Small and Large Intestine","longName":"3153873","preferredDefinition":"(in-TES-tin) The long, tube-shaped organ in the abdomen that completes the process of digestion. There is both a large intestine and a small intestine. Also called the bowel.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intestine","conceptCode":"C12736","definition":"The portion of the gastrointestinal tract between the stomach and the anus. It includes the small intestine and large intestine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"94041146-9B3F-BCDC-E040-BB89AD4370F7","latestVersionIndicator":"Yes","beginDate":"2010-11-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9AC65E5B-B6AE-5617-E040-BB89AD43498C","beginDate":"2011-01-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-01-26","modifiedBy":"ONEDATA","dateModified":"2011-01-26","deletedIndicator":"No"},{"value":"Subcutaneous Tissue","valueDescription":"Subcutaneous Tissue","ValueMeaning":{"publicId":"3187285","version":"1","preferredName":"Subcutaneous Tissue","longName":"3187285","preferredDefinition":"Beneath the skin.: An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Subcutaneous","conceptCode":"C13353","definition":"Beneath the skin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Tissue","conceptCode":"C12801","definition":"An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9AC65E5B-B6BC-5617-E040-BB89AD43498C","latestVersionIndicator":"Yes","beginDate":"2011-01-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-01-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9AC65E5B-B6D5-5617-E040-BB89AD43498C","beginDate":"2011-01-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-01-26","modifiedBy":"ONEDATA","dateModified":"2011-01-26","deletedIndicator":"No"},{"value":"Skin","valueDescription":"Skin","ValueMeaning":{"publicId":"2816295","version":"1","preferredName":"Skin","longName":"2816295","preferredDefinition":"1. An organ and the enveloping membrane of the body; includes, in addition to the epidermis and dermis, all of the derivatives of the epidermis, e.g., hairs, nails, sudoriferous and sebaceous glands, and mammary glands. Subdivisions of the skin surround various body parts; as a whole, the skin constitutes the external surface of the body. 2. The rind, capsule, or covering of any body or part.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Skin","conceptCode":"C12470","definition":"An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5E266FBD-287B-AD47-E040-BB89A64327A4","latestVersionIndicator":"Yes","beginDate":"2008-12-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-12-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9AC65E5B-B6DF-5617-E040-BB89AD43498C","beginDate":"2011-01-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-01-26","modifiedBy":"ONEDATA","dateModified":"2011-01-26","deletedIndicator":"No"},{"value":"Brain/CNS","valueDescription":"Central Nervous System","ValueMeaning":{"publicId":"5343370","version":"1","preferredName":"Central Nervous System","longName":"5343370","preferredDefinition":"The part of the nervous system that consists of the brain, spinal cord, and meninges.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Central Nervous System","conceptCode":"C12438","definition":"The part of the nervous system that consists of the brain, spinal cord, and meninges.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"37781D63-993B-FF48-E050-BB89AD433A9A","latestVersionIndicator":"Yes","beginDate":"2016-07-12","endDate":null,"createdBy":"DWARZEL","dateCreated":"2016-07-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"37781D63-9953-FF48-E050-BB89AD433A9A","beginDate":"2016-07-12","endDate":null,"createdBy":"DWARZEL","dateCreated":"2016-07-12","modifiedBy":"ONEDATA","dateModified":"2016-07-12","deletedIndicator":"No"},{"value":"Eye","valueDescription":"Eye","ValueMeaning":{"publicId":"3689467","version":"1","preferredName":"Eye","longName":"3689467","preferredDefinition":"The organ of sight or vision.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Eye","conceptCode":"C12401","definition":"The organ of sight or vision.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D633790D-8703-98CF-E040-BB89AD430ABB","latestVersionIndicator":"Yes","beginDate":"2013-02-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3776D628-8105-FDB2-E050-BB89AD437DA5","beginDate":"2016-07-12","endDate":null,"createdBy":"DWARZEL","dateCreated":"2016-07-12","modifiedBy":"ONEDATA","dateModified":"2016-07-12","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3187283","version":"1","preferredName":"Radiation Therapy Oncology Group Late Effects Adverse Event Name","preferredDefinition":"The Radiation Therapy Oncology Group (RTOG) is a multi-institutional cooperative organization, a national cancer study research group comprised of 250 of the major research institutions nationally and in Canada, funded by NCI, headquartered in Philadelphia with almost 30 years of experience in running clinical trials. More than 40 clinical trials that involve radiation therapy either alone or in conjunction with surgery and/or chemotherapeutic drugs are active at any one time within RTOG. The group is interested in quality of life issues and their effects on the cancer patient:Symptoms and conditions which are the result of treatment but arise months or years after the therapy.:Any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, syndrome, or disease, temporally associated with the use of a medical product or procedure, regardless of whether or not it is considered related to the product or procedure (attribution of unrelated, unlikely, possible, probable, or definite). The concept refers to events that could be medical product related, dose related, route related, patient related, caused by an interaction with another therapy or procedure, or caused by opioid initiation or dose escalation. The term also is referred to as an adverse experience. The old term Side Effect is retired and should not be used.:The words or language units by which a thing is known.","longName":"C19778:C4808:C41331:C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Radiation Therapy Oncology Group","conceptCode":"C19778","definition":"A multi-institutional cooperative organization, a national cancer study research group comprised of 250 of the major research institutions nationally and in Canada, funded by NCI, headquartered in Philadelphia with almost 30 years of experience in running clinical trials. More than 40 clinical trials that involve radiation therapy either alone or in conjunction with surgery and/or chemotherapeutic drugs are active at any one time within RTOG. The group is interested in quality of life issues and their effects on the cancer patient","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Late Adverse Effect","conceptCode":"C4808","definition":"Any symptom or condition which is a result of a medical intervention but arises months or years after it.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Adverse Event","conceptCode":"C41331","definition":"Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9AC65E5B-B655-5617-E040-BB89AD43498C","latestVersionIndicator":"Yes","beginDate":"2011-01-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-01-26","modifiedBy":"ONEDATA","dateModified":"2011-01-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CTCAEv4.0:Common Terminology Criteria for Adverse Events v4.0","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9AC65E5B-B666-5617-E040-BB89AD43498C","latestVersionIndicator":"Yes","beginDate":"2011-01-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-01-26","modifiedBy":"DWARZEL","dateModified":"2016-07-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Late RTOG Toxicity","type":"Preferred Question Text","description":"Late RTOG Toxicity","url":null,"context":"CCR"}],"origin":"RTOG CRF:Radiation Therapy Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9AC6E59A-978A-5F20-E040-BB89AD436844","latestVersionIndicator":"Yes","beginDate":"2011-01-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-01-26","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeDescription":"Curated for CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}